August 2, 2010 ·
Key opinion leaders (KOLs) are health care leaders who make a high-impact footprint while advancing medical science. Thought Leader Select specializes in delivering objective, validated data on the skills and experiences of KOLs, so that pharmaceutical companies can seek their advice and guidance in the development of new medicines.
Over the past several years, Thought Leader Select has studied physician key opinion leaders who treat diabetes and analyzed their involvement in many areas, including clinical research, treatment guidelines involvement, publishing, reimbursement involvement and participation in advocacy efforts. In a recent assessment of nearly 500 diabetes KOLs across the United States, Thought Leader Select examined their participation in patient advocacy activities. Using keywords to link these KOLs with such activities, Thought Leader Select found that 62% of physicians regularly take part in patient advocacy efforts, such as participation in advocacy organizations, patient education or legislative efforts (see Chart 1).
Of the 301 KOLs with advocacy involvement, most take part in five or fewer activities, while only 3% of them boast 10 or more advocacy activities and/or awards. In addition to activities through the American Diabetes Association (ADA) and American Association of Clinical Endocrinologists (AACE) – especially the American College of Endocrinology’s Power of Prevention (POP) program – top advocacy initiatives and organizations include:
• Taking ... read more »
July 14, 2010 ·
Leave a comment
Brian Castle joined Thought Leader Select in January of 2010, as director of global marketing and client relations. Brian has 12 years of experience leading teams in business development, sales, marketing and customer services. He spent 11 years in the financial services industry, managing business units for several top banking institutions. Upon leaving the financial sector, Brian used his expertise in business development, communications and marketing to help business and non-profit clients develop and execute marketing, social media and branding strategies. In his new role at Thought Leader Select, Brian is helping the company expand its sales and marketing efforts and create a larger presence in the KOL identification and profiling marketplace.
The Thought Leader Select Blog sat down with Brian, the powerhouse behind Thought Leader Select’s social media strategy, to learn more about his role within the company, what drives him at work and the extracurricular passions that make him unique.
TLS Blog: Good morning, Brian. What made you sign on with Thought Leader Select?
Brian Castle: I spent most of my career working in the financial services industry. When the industry started experiencing its recent turmoil, I decided it was time to make a change. So I reached out to several business owners and started collaborating with them on a host of projects in marketing, business development, social media, and public ... read more »
May 6, 2010 ·
Leave a comment
Kristen Smithwick joined Thought Leader Select as its director of research operations in 2006. Kristen leads sales, marketing and strategic planning in her current role as vice president of the company. A 1998 graduate of Duke University, Kristen spent the first seven years of her career as manager of membership services at a North Carolina firm providing best practice benchmarking services to the biopharmaceutical, medical device, and health care industries.
The Thought Leader Select Blog recently sat down to catch up with Kristen Smithwick to learn about her background and how she makes her professional contribution to the work of Thought Leader Select.
TLS Blog: Good morning, Kristen. Tell us why you joined Thought Leader Select.
Kristen Smithwick: After seven years working to help a small company grow its market share, I wanted a new, different challenge in my career. I saw a great opportunity at Thought Leader Select—I loved the concept that Paul Meade and Lisa Smith (Thought Leader Select’s founders) had put together. This concept—providing unbiased, objective data on key opinion leaders to assist pharmaceutical companies in developing new medicines—was something we all thought the industry really needed. I had worked with Paul and Lisa at my previous company, and I appreciated Lisa’s sharp-minded approach to research and Paul’s big-picture, strategic mindset.
TLS Blog: How does your academic background and/or professional career ... read more »